Riskpilot← Back to searchSign inGet full accessLINK MEDICAL RESEARCH AS
ASActiveOrg 975384047Drammensveien 288, 0283 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 199533 employees
Revenue 2024
NOK 70M
-7% vs 2023
EBITDA margin
-5.5%
+57% vs 2023
Equity ratio
15.2%
Financial strength
Net profit 2024
NOK -1,7M
+67% vs 2023
| Revenue | NOK 70M | -7% |
| EBITDA | NOK -3,9M | +57% |
| Net profit | NOK -1,7M | +67% |
| Total assets | NOK 70,4M | +21% |
| Equity | NOK 10,7M | -14% |
| Employees | 33 | — |
Legal name
LINK MEDICAL RESEARCH AS
Org number
975384047
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12. september 1995
Share capital
NOK 13 400 000
Employees
33 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Drammensveien 288, 0283 Oslo
Phone
+4722589000
Email
norway@linkmedical.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 74 690 | 81 274 | 77 709 | 74 986 | 70 004 |
| Staff expenses | −53 424 | −58 352 | −60 671 | −55 440 | −45 446 |
| EBITDA | −6 701 | 2 953 | −6 403 | −8 958 | −3 867 |
| Depreciation & amort. | −291 | −410 | −506 | −296 | −243 |
| EBIT | −6 992 | 2 542 | −6 910 | −9 254 | −4 110 |
| Net financials | 3 518 | −4 061 | 5 542 | 2 245 | 1 874 |
| Profit before tax | −3 473 | −1 519 | −1 367 | −7 010 | −2 237 |
| Tax | −896 | 2 488 | −2 679 | −1 794 | −492 |
| Net profit | −2 577 | −4 007 | 1 311 | −5 216 | −1 745 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 80 233 | 59 657 | 67 992 | 58 225 | 70 395 |
| Equity | 18 360 | 16 353 | 17 664 | 12 449 | 10 704 |
| Long-term debt | 35 409 | 20 412 | 16 396 | 8 888 | 29 061 |
| Short-term debt | 26 464 | 22 892 | 33 931 | 36 889 | 30 629 |
| Total debt | 61 873 | 43 304 | 50 327 | 45 777 | 59 691 |
EBITDA margin
-5.5%
This company
15.8%
Market median
-135% vs market
20202024
Equity ratio
15.2%
This company
38.2%
Market median
-60% vs market
20202024
Return on equity
-16.3%
This company
18.4%
Market median
-189% vs market
20202024
Net profit margin
-2.5%
This company
8.1%
Market median
-131% vs market
20202024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
5.58×
This company
0.62×
Market median
-800% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
TI Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
OG Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Chairman | 2019 – 2022 | |
| Chairman | 2023 – 2025 | |
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Serendipity Bobcat Holding AsBobcat Holding AsLink Medical As
LINK MEDICAL RESEARCH AS (this company)Board members of LINK MEDICAL RESEARCH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Ivar Horvei | Chief Executive Officer | 0 companies |
| Ola Gudmundsen | Chief Executive Officer | 0 companies |
| Carl Anders Göransson | Chairman | 0 companies |
| Jørgen Waaler | Chairman | 0 companies |
| Jan Helge Golmen | Board of Directors | 0 companies |
| Sissel Lønning Andresen | Chairman | 0 companies |
| Per Herseth | Board of Directors | 0 companies |